Since MAP4K4 was at the upstream of SOX6-induced autophagy, its inhibitor might be more specific in inhibiting autophagy and subsequently increasing the sensitivity of cervical cancer cells to cisplatin chemotherapy. This evidence concerns the gene SOX6 and cervical carcinoma.